CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Clinical trials for CHRONIC OBSTRUCTIVE PULMONARY DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC OBSTRUCTIVE PULMONARY DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inhaled treprostinil safety trial for PH-COPD ends early
Disease control TerminatedThis study looked at the long-term safety of an inhaled drug called treprostinil in people who have both pulmonary hypertension (high blood pressure in the lungs) and COPD. It included 41 adults who had already completed a previous study. The trial was terminated early, and the m…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Probiotic study for diabetes and COPD halted early
Disease control TerminatedThis study looked at whether taking probiotics alongside regular treatment could help lower blood sugar and improve lung function in people with both type 2 diabetes and chronic obstructive pulmonary disease (COPD). The trial planned to enroll 30 adults aged 50-85, but it was ter…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Glac Biotech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New COPD inhaler Add-On studied, but trial halted early
Disease control TerminatedThis study tested two doses of an inhaled drug called CHF6001 (Tanimilast) added to standard triple therapy in people with severe COPD and chronic bronchitis. The goal was to see if it could reduce the number of moderate or severe flare-ups over a year. The trial was terminated e…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New inhaler for COPD shows promise in early trial
Disease control TerminatedThis study tested an experimental inhaled drug called HRG2005 in people with moderate to severe chronic obstructive pulmonary disease (COPD). The goal was to see if it improves lung function compared to a standard treatment. About 82 participants were enrolled, but the study was …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
COPD drug trial halted: new Add-On therapy falls short
Disease control TerminatedThis study tested an inhaled drug called CHF6001 (Tanimilast) in people with COPD and chronic bronchitis who were already on triple therapy. The goal was to see if adding this drug could reduce flare-ups. The trial was stopped early and involved about 4,700 participants.
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New inhaled therapy targets mucus in asthma and COPD – but trial halted early
Disease control TerminatedThis early-phase trial tested an inhaled drug called ARO-MUC5AC in healthy volunteers and people with asthma or COPD. The goal was to see if it is safe and how it affects lung function by targeting mucus production. The study was terminated early, so we have less information than…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can rehab at home beat the clinic for COPD patients?
Symptom relief TerminatedThis study looked at whether doing breathing and exercise training at home works as well as doing it at a rehab center for people with chronic obstructive pulmonary disease (COPD). The goal was to see if home rehab could improve exercise tolerance just as much, while also being c…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Can bringing palliative care home ease suffering?
Symptom relief TerminatedThis study tested whether providing palliative care at home, through a team of doctors, nurses, social workers, and chaplains, could improve symptoms and quality of life for people with advanced cancer, heart failure, or COPD. The plan was to enroll over 1,100 patients, but the t…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
AI stethoscope could spot lung disease patterns
Knowledge-focused TerminatedThis study tested whether artificial intelligence can detect and classify abnormal lung sounds in people with cystic fibrosis, COPD, or pulmonary fibrosis. Researchers recorded lung sounds with an electronic stethoscope during routine checkups and analyzed them using AI. The goal…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Breathing in a special gas reveals hidden lung damage in transplant patients
Knowledge-focused TerminatedThis study used a special MRI technique with a harmless gas called hyperpolarized xenon-129 to take detailed pictures of lung function in people who had a lung transplant. The goal was to see if this scan could detect early signs of chronic lung allograft dysfunction (CLAD), a co…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Xemed LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC